Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7671108rdf:typepubmed:Citationlld:pubmed
pubmed-article:7671108lifeskim:mentionsumls-concept:C0206679lld:lifeskim
pubmed-article:7671108lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:7671108lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:7671108lifeskim:mentionsumls-concept:C0027754lld:lifeskim
pubmed-article:7671108lifeskim:mentionsumls-concept:C0085262lld:lifeskim
pubmed-article:7671108lifeskim:mentionsumls-concept:C0027752lld:lifeskim
pubmed-article:7671108lifeskim:mentionsumls-concept:C0086022lld:lifeskim
pubmed-article:7671108lifeskim:mentionsumls-concept:C1705099lld:lifeskim
pubmed-article:7671108lifeskim:mentionsumls-concept:C0442335lld:lifeskim
pubmed-article:7671108lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:7671108pubmed:issue5lld:pubmed
pubmed-article:7671108pubmed:dateCreated1995-10-19lld:pubmed
pubmed-article:7671108pubmed:abstractTextWe have developed an HSV-1 vector with mutations in the viral IE 3 and VP16 genes that expresses mouse beta nerve growth factor (NGF) from a latency associated transcript (LAT) promoter modified by insertion of a Rous sarcoma virus (RSV) enhancer. The backbone double mutant vector has reduced cytotoxicity compared with a single mutant deleted for IE 3 and is able to express the reporter luciferase gene in rat pheochromocytoma (PC12) cells at low but relatively stable levels in vitro. Intracellular NGF levels of approximately 3 pg per mg of cellular protein were detected in infected PC12 cells for at least 7 days after infection. Furthermore, infected PC12 cells exhibited differentiated morphology marked by neurite outgrowth similar to that found after exposure of PC12 cells to purified 2.5S beta NGF. A persistent level of 0.2 to 0.3 pM of the expressed NGF was detected in the culture media. The NGF-expressing vector also showed reduced cytotoxicity compared with that of the parental virus in infected PC12 cells. In PC12 cells that overexpress the human proto-oncogene bcl-2, the cytotoxicity of both viruses was significantly reduced. These studies demonstrate that the reduced cytotoxicity of the IE 3-VP16 double mutant virus and the increased duration of transgene expression from the RSV-modified LAT promoter permit terminal differentiation of PC12 cells after infection with an NGF-expressing HSV-1 vector.lld:pubmed
pubmed-article:7671108pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7671108pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7671108pubmed:languageenglld:pubmed
pubmed-article:7671108pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7671108pubmed:citationSubsetIMlld:pubmed
pubmed-article:7671108pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7671108pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7671108pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7671108pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7671108pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7671108pubmed:statusMEDLINElld:pubmed
pubmed-article:7671108pubmed:monthJullld:pubmed
pubmed-article:7671108pubmed:issn0969-7128lld:pubmed
pubmed-article:7671108pubmed:authorpubmed-author:FriedmannTTlld:pubmed
pubmed-article:7671108pubmed:authorpubmed-author:JohnsonP APAlld:pubmed
pubmed-article:7671108pubmed:authorpubmed-author:WangM JMJlld:pubmed
pubmed-article:7671108pubmed:issnTypePrintlld:pubmed
pubmed-article:7671108pubmed:volume2lld:pubmed
pubmed-article:7671108pubmed:ownerNLMlld:pubmed
pubmed-article:7671108pubmed:authorsCompleteYlld:pubmed
pubmed-article:7671108pubmed:pagination323-35lld:pubmed
pubmed-article:7671108pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:meshHeadingpubmed-meshheading:7671108-...lld:pubmed
pubmed-article:7671108pubmed:year1995lld:pubmed
pubmed-article:7671108pubmed:articleTitleDifferentiation of PC12 cells by infection with an HSV-1 vector expressing nerve growth factor.lld:pubmed
pubmed-article:7671108pubmed:affiliationDepartment of Pediatrics, University of California at San Diego, La Jolla 92093-0634, USA.lld:pubmed
pubmed-article:7671108pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7671108pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7671108pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7671108lld:pubmed